# Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/durvalumab-with-olaparib-and-paclitaxel-for-high-risk-her2-negative-stage-ii-iii/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lajos Pusztai,Christina Yau,Denise M. Wolf,Hyo S. Han,Lili Du,Anne M. Wallace,Erica String-Reasor,Judy C. Boughey,A. Jo Chien,Anthony Elias,Heather Beckwith,Rita Nanda,Kathy S. Albain,Amy S. Clark,Kathleen Kemmer,Kevin Kalinsky,Claudine Isaacs,Alexandra Thomas,Rebecca Shatsky,Theresa L. Helsten,Andres Forero‐Torres,Minetta C. Liu,Lamorna Brown Swigart,Emmanuel Petricoin,Julia Wulfkuhle,Smita Asare,Amy Wilson,Ruby Singhrao,Laura Sit,Gillian L. Hirst,Scott Berry,Ashish Sanil,Adam L. Asare,Jeffrey B. Matthews,Jane Perlmutter,Michelle Melisko,Hope S. Rugo,Richard B. Schwab,W. Fraser Symmans,Douglas Yee,Laura J. van’t Veer,Nola M. Hylton,Angela DeMichele,Donald A. Berry,Laura J. Esserman |
| Citations | 339 |
| DOI | 10.1016/j.ccell.2021.05.009 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.cell.com/article/S1535610821002750/pdf |
| OpenAlex ID | https://openalex.org/W3172174831 |
| PMID | 34143979 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Judy C. Boughey](https://scholariq.org/researchers/judy-c-boughey/)
- [A. Jo Chien](https://scholariq.org/researchers/a-jo-chien/)
- [Christina Yau](https://scholariq.org/researchers/christina-yau/)
- [Anne M. Wallace](https://scholariq.org/researchers/anne-m-wallace/)
- [Laura J. Esserman](https://scholariq.org/researchers/laura-j-esserman/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.